Concepedia

Ginny D. Ho

GD

Statistics

Publications

24

Citations

665

H-Index

14

Active since

1997

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

AGCO (United Kingdom)

Institute of Neurobiology

Albany Molecular Research (United States)

University of Florida

Ginny D. Ho is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1997–2017

24

Publications

24

The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)

Geoffrey B. Varty, Sherry Lu, Cynthia A. Morgan et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 83 citations

, , +16

SCH-202676: An Allosteric Modulator of Both Agonist and Antagonist Binding to G Protein-Coupled Receptors

Ahmad Fawzi, Douglas Macdonald, Lawrence L. Benbow et al. · Molecular Pharmacology · 2001 · 80 citations

, , +17

Potent Tetracyclic Guanine Inhibitors of PDE1 and PDE5 Cyclic Guanosine Monophosphate Phosphodiesterases with Oral Antihypertensive Activity

Ho-Sam Ahn, Ana Bercovici, George Boykow et al. · Journal of Medicinal Chemistry · 1997 · 80 citations · Full text

, , +16

Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia

Shu‐Wei Yang, Jennifer Smotryski, William T. McElroy et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 52 citations · Full text

, , +9

Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation

William T. McElroy, Zheng Tan, Ginny D. Ho et al. · ACS Medicinal Chemistry Letters · 2015 · 40 citations · Full text

, , +15

1–5 of 24